Pharmacy

In recent months, several drug giants announced they are exploring deals or have completed deals to expand their portfolios of cancer medications.

Drug giant Eli Lilly will cut 250 jobs at its factory in Eastern France, according to Reuters.

Patients for Affordable Drugs, affordable drug advocates, will launch a $1 million ad campaign to help one of the Trump administration's drug-pricing proposals gain traction, according to STAT.

Snehal Doshi, PharmD, vice president of pharmacy services for Marietta, Ga.-based WellStar Health System, spoke with Becker's Hospital Review about the disruptors that have his attention and the skills pharmacy leaders need in today's rapidly changing healthcare climate.

Louisiana officials will proceed with establishing a Netflix-style payment model for hepatitis C treatments, STAT reports.

Despite fervent objection from diabetes patients and advocates, European drugmakers Novo Nordisk and Sanofi have raised the prices of insulin in the U.S., according to the Financial Times.

After more than 30 drugmakers ushered in the new year with a wave of price hikes, another pharma giant, Johnson & Johnson, is following suit.

Biosimilars are reshaping the treatment landscape for biologic-based therapies. In addition to producing clinically-equivalent outcomes to their reference products, studies show biosimilars will contribute to lowering the overall cost of healthcare1.

Pfizer will lay off 1,700 employees and cease manufacturing "immediately" at two plants in India, according to The Hindu Business Line.

Drugmaker Lupin Somerset is recalling 23,460 bottles of Nitrofurantoin, an oral antibiotic used for the treatment and prevention of  bladder infections, according to The Economic Times.